abstract |
The present invention provides a peptide compound Met-Pro-His-Ser as a therapeutic agent for preventing and / or treating cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, cardiovascular diseases and metabolic diseases. -Phe-Ala-Asn-Leu-Pro-Leu-Arg-Phe-NH 2 . The invention also optionally comprises peptide Met-Pro-His-Ser-Phe-Ala-, in combination with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and / or diluent. It relates to a pharmaceutical composition containing Asn-Leu-Pro-Leu-Arg-Phe-NH 2 , preferably in the form of a lyophilizate or liquid buffer or artificial breast milk preparation or breast milk substitute. |